In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...
Dr Anne Peters discusses how to safely prescribe SGLT2 inhibitors in patients with type 1 diabetes to prevent diabetic ketoacidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback